Marshall Wace, LLP Epizyme, Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

Shares

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$6.81 - $9.71 $1.41 Million - $2.02 Million	-207,760 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.45 - $12.32 $1.55 Million - $2.56 Million	207,760 New	207,760 $1.81 Million
Q3 2020 Nov 16, 2020	SELL	$11.73 - $16.25 $872,676 - $1.21 Million	-74,397 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$13.68 - $20.46 $494,641 - $739,792	36,158 Added 94.56%	74,397 $1.2 Million
Q1 2020 May 15, 2020	BUY	$14.83 - $26.72 $567,084 - $1.02 Million	38,239 New	38,239 $593,000
Q2 2019 Aug 14, 2019	SELL	$11.43 - $15.12 $2.19 Million - $2.9 Million	-191,674 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$5.98 - $13.98 $2.33 Million - $5.46 Million	-390,429 Reduced 67.07%	191,674 $2.38 Million
Q4 2018 Feb 14, 2019	BUY	$5.22 - $10.44 $1.38 Million - $2.76 Million	264,052 Added 83.02%	582,103 $3.59 Million
Q3 2018 Nov 14, 2018	BUY	$9.5 - $13.75 $3.02 Million - $4.37 Million	318,051 New	318,051 $3.37 Million
Q2 2018 Aug 14, 2018	SELL	$12.85 - $18.45 $830,765 - $1.19 Million	-64,651 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$12.5 - $19.75 $808,137 - $1.28 Million	64,651 New	64,651 $1.15 Million

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.